Seasonal Allergic Conjunctivitis Clinical Trial
Official title:
A Phase 3, Multicenter, Randomized, Double-masked, Active Controlled Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops 0.05% in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients
The goal of this multicenter, randomized, double-blind, active control, non-inferiority clinical trial is to evaluate the efficacy of epinastine hydrochloride eye drops for the treatment of seasonal allergic conjunctivitis using azelastine hydrochloride eye drops as a positive control in Chinese patients. The main question it aims to answer are: • Is the efficacy for of epinastine hydrochloride eye drops for the treatment of seasonal allergic conjunctivitis non-inferior to azelastine hydrochloride eye drops?Participants will be randomly assigned to the test group or control group in a 1:1 ratio. The test group was treated with epinastine hydrochloride eye drops + azelastine hydrochloride simulating eye drops, and the control group was treated with azelastine hydrochloride eye drops + epinastine hydrochloride simulating eye drops, which were used twice a day for 14 consecutive days.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05591755 -
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
|
Phase 3 | |
Withdrawn |
NCT01541904 -
Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
|
Phase 2 | |
Completed |
NCT01435460 -
Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
|
Phase 3 | |
Completed |
NCT01342601 -
Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents
|
N/A | |
Completed |
NCT01344083 -
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
|
Phase 2 | |
Completed |
NCT00133627 -
Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
|
Phase 4 |